A Phase 1 study of oral Kevetrin to evaluate safety and toleration in healthy volunteers.
Phase of Trial: Phase I
Latest Information Update: 30 Dec 2016
At a glance
- Drugs Thioureidobutyronitrile (Primary)
- Indications Breast cancer; Chronic myeloid leukaemia; Colorectal cancer; Glioblastoma; Head and neck cancer; Lung cancer; Lymphoma; Multiple myeloma; Ovarian cancer; Pancreatic cancer; Prostate cancer; Renal cancer; Retinoblastoma; Solid tumours
- Focus Adverse reactions
- 30 Dec 2016 New trial record